- Home
- EVOK vs IMCC Comparison
EVOK vs IMCC Comparison
Compare EVOK & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVOK
- IMCC
- Stock Information
- Founded
- EVOK 2007
- IMCC 1980
- Country
- EVOK United States
- IMCC Israel
- Employees
- EVOK N/A
- IMCC N/A
- Industry
- EVOK Biotechnology: Pharmaceutical Preparations
- IMCC Medicinal Chemicals and Botanical Products
- Sector
- EVOK Health Care
- IMCC Health Care
- Exchange
- EVOK Nasdaq
- IMCC Nasdaq
- Market Cap
- EVOK 4.3M
- IMCC 5.0M
- IPO Year
- EVOK 2013
- IMCC N/A
- Fundamental
- Price
- EVOK $4.41
- IMCC $2.70
- Analyst Decision
- EVOK
- IMCC
- Analyst Count
- EVOK 0
- IMCC 0
- Target Price
- EVOK N/A
- IMCC N/A
- AVG Volume (30 Days)
- EVOK 1.2M
- IMCC 26.0K
- Earning Date
- EVOK 11-07-2024
- IMCC 11-14-2024
- Dividend Yield
- EVOK N/A
- IMCC N/A
- EPS Growth
- EVOK N/A
- IMCC N/A
- EPS
- EVOK N/A
- IMCC N/A
- Revenue
- EVOK $8,617,036.00
- IMCC $38,042,859.00
- Revenue This Year
- EVOK $124.10
- IMCC $22.59
- Revenue Next Year
- EVOK $75.70
- IMCC $20.53
- P/E Ratio
- EVOK N/A
- IMCC N/A
- Revenue Growth
- EVOK 100.35
- IMCC N/A
- 52 Week Low
- EVOK $3.54
- IMCC $1.13
- 52 Week High
- EVOK $17.40
- IMCC $8.10
- Technical
- Relative Strength Index (RSI)
- EVOK 40.54
- IMCC 62.45
- Support Level
- EVOK $4.28
- IMCC $2.48
- Resistance Level
- EVOK $4.79
- IMCC $3.02
- Average True Range (ATR)
- EVOK 0.45
- IMCC 0.29
- MACD
- EVOK -0.13
- IMCC 0.06
- Stochastic Oscillator
- EVOK 22.82
- IMCC 62.13
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.